Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Times Interest Earned: 2012-2025

Historic Times Interest Earned for Fennec Pharmaceuticals (FENC) over the last 5 years, with Sep 2025 value amounting to -$0.32.

  • Fennec Pharmaceuticals' Times Interest Earned rose 93.64% to -$0.32 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.70, marking a year-over-year decrease of 506.35%. This contributed to the annual value of $0.63 for FY2024, which is 116.77% up from last year.
  • According to the latest figures from Q3 2025, Fennec Pharmaceuticals' Times Interest Earned is -$0.32, which was up 92.99% from -$4.60 recorded in Q2 2025.
  • Over the past 5 years, Fennec Pharmaceuticals' Times Interest Earned peaked at $13.29 during Q1 2024, and registered a low of -$1,231 during Q1 2021.
  • For the 3-year period, Fennec Pharmaceuticals' Times Interest Earned averaged around -$1.75, with its median value being -$1.99 (2023).
  • Data for Fennec Pharmaceuticals' Times Interest Earned shows a peak YoY increase of 301.26% (in 2024) and a maximum YoY decrease of 327.17% (in 2024) over the last 5 years.
  • Quarterly analysis of 5 years shows Fennec Pharmaceuticals' Times Interest Earned stood at -$75.87 in 2021, then rose by 12.51% to -$10.47 in 2022, then skyrocketed by 81.03% to -$1.99 in 2023, then surged by 51.34% to -$0.97 in 2024, then soared by 93.64% to -$0.32 in 2025.
  • Its Times Interest Earned stands at -$0.32 for Q3 2025, versus -$4.60 for Q2 2025 and -$1.36 for Q1 2025.